Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: Correlation with cerebrospinal fluid pressure

AIDS

Volumn 24, Issue 3, 2010, Pages 405-410

  Loyse, Angela ^a,b,c   Wainwright, Helen ^d   Jarvis, Joseph N ^a,b,c   Bicanic, Tihana ^a,b,c   Rebe, Kevin ^a,b   Meintjes, Graeme ^a,b   Harrison, Thomas S ^c  

^a GF Jooste Hospital   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d Department of Pathology ^*

Author keywords

Arachnoid granulation; Cerebrospinal fluid pressure; Cryptococcal meningitis; Cryptococcus; Histopathology; HIV; Raised intracranial pressure

Indexed keywords

ANAMNESIS; ARTICLE; AUTOPSY; BRAIN ARACHNOID; CELL INFILTRATION; CEREBROSPINAL FLUID PRESSURE; CLINICAL FEATURE; CORRELATION ANALYSIS; CRYPT CELL; CRYPTOCOCCAL MENINGITIS; DISEASE ASSOCIATION; FUNGAL CELL; GRANULATION TISSUE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY INFILTRATE; PRIORITY JOURNAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ARACHNOID; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID PRESSURE; DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; INTRACRANIAL HYPERTENSION; MALE; MENINGITIS, CRYPTOCOCCAL;

EID: 75649136209     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328333c005     Document Type: Article

References (17)

1. Park B, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller T. Estimation of the global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23:525-530.
2. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000; 30: 47-54.
3. Pappas PG. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-asso-ciated cryptococcal meningitis. Clin Infect Dis 2009; 48:1775-1783.
4. Saag MS, Graybill RJ, Larsen RA, Pappas MS, Perfect JR, Pow-derly WG, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000; 30:710-718.
5. Bicanic T, Brouwer AE, Meintjes G, Rebe K, Limmathurotsakul D, Chierakul W, et al. Relationship of CSF pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 2009; 23:701-706.
6. Denning DW, Armstrong RW, Stevens DA. Elevated cerebrosp-inal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991; 91:267-272.
7. Kida S, Yamashima T, Kubota T, Ito H, Yamamoto S. A light and electron microscopic and immunohistochemical study of human arachnoid villi. J Neurosurg 1988; 69:429-435.
8. Massicote EM, Del Bigio MR. Human arachnoid villi response to subarachnoid hemorrhage: possible relationship to chronic hydrocephalus. J Neurosurg 1999; 91:80-84.
9. Lee SC, Dickson DW, Casadevall A. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol 1996; 27:839-847.
10. Kapoor KG, Katz SE, Grzybowski DM, Lubow M. Cerebrospinal fluid outflow: an evolving perspective. Brian Res Bull 2008; 77:327-334.
11. Conegero CI, Chopard RP. Tridimensional architecture of the collagen element in the arachnoid granulations in humans. Arq Neuropsiquiatr 2003; 61:561-565.
12. Welch K, Pollay M. Perfusion of particles through arachnoid villi of the monkey. Am J Physiol 1961; 201:651-654.
13. Adams JE, Prawirohardjo S. Fate of red cells injected into cerebrospinal fluid pathways. Neurology 1959; 9:561.
14. Glimcher SA, Holman DW, Lubow M, Grzybowski DM. Ex vivo model of cerebrospinal fluid outflow across human archnoid granulations. Invest Opthalmol Vis Sci 2008; 49:4721-4728.
15. Yamashima T. Ultrastructural study of the final cerebrospinal fluid pathway in human arachnoid villi. Brain Res 1986; 384:68-76.
16. Shoham S, Cover C, Donegan N, Fulnecky E, Kumar P. Cryp-tococcus neoformans meningitis at 2 hospitals in Washington, D.C.: adherence of healthcare providers to published practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2005; 40:477-479.
17. Fries BC, Lee SC, Keenan R, Zhao W, Casadevall A, Goldman DL. Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningiencephalitis. Infect Immun 2005; 73:1779-1787.